Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Scientists Discover 'Natural Barrier' to HIV


Related Encyclopedia
 border=
Abscess
Actinomycosis
Acute Myeloid Leukemia (Adult)
AIDS and HIV Infection
More...

Related Healthscout Videos
 border=
Fighting HIV
Fighting a Killer Staph Infection
Medical Debate: C-sections - Should You Choose?
Ultrasound For Prostate Cancer
More...

Related Animations
 border=
Erectile Dysfunction
Menopause
More...

Related Drug Information
 border=
Abilify
Augmentin
Bactroban Cream
Bactroban Ointment
More...

Related News Articles
 border=
Health Tip: Before You Get Pregnant
Most Internet Sex Offenders Target Teens, Not Kids
Stimulating Thymus Reactivates T-Cell Production
FDA Panel OKs 3 New Flu Strains for Next Year's Vaccine
More...


Page:  << Prev | 1 | 2 | 3 | Next >>

Experts have long puzzled why HIV is relatively tough to contract, compared to other pathogens. The Dutch study, conducted in the laboratory using Langerhans cells from 13 human donors, may explain why.

When HIV comes in contact with genital mucosa, its ultimate target -- the cells it seeks to hijack and destroy -- are immune system T-cells. But T-cells are relatively far away (in lymph tissues), so HIV uses nearby Langerhans cells as "vehicles" to migrate to T-cells.

For decades, the common wisdom was that HIV easily enters and infects Langerhans cells. Geijtenbeek's team has now cast doubt on that notion.

Text Continues Below



Looking closely at the interaction of HIV and Langerhans cells, they found that the cells "do not become infected by HIV-1, because the cells have the protein Langerin on their cell surface," Geijtenbeek said. "Langerin captures HIV-1 very efficiently, and this Langerin-bound HIV-1 is taken up (a bit like eating) by the Langerhans cells and destroyed."

In essence, Geijtenbeek said, "Langerhans cells act more like a virus vacuum cleaner."

Only in certain circumstances -- such as when levels of invading HIV are very high, or if Langerin activity is particularly weak -- are Langerhans cells overwhelmed by the virus and infected.

The finding is exciting for many reasons, not the least of which is its potential for HIV prevention, Geijtenbeek said.

"We are currently investigating whether we can enhance Langerin function by increasing the amount of Langerin on the cell surface of Langerhans cells," he said. "This might be a real possibility, but it will take time. I am also confident that other researchers will now also start exploring this possibility."

The discovery might also help explain differences in vulnerability to HIV infection among people.

"It is known that the Langerin gene is different in some individuals," Geijtenbeek noted. "These differences could affect the function of Langerin. Thus, Langerhans cells with a less functional Langerin might be more susceptible to HIV-1, and these individuals are more prone to infection. We are currently investigating this."

Page:  << Prev | 1 | 2 | 3 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 3/5/2007

Related Links
 border=
From Healthscout's partner site on genital herpes, HerpesConnection.com
Learn about genital herpes symptoms
What are herpes treatment options?
Get the details about herpes simplex 1 and 2.





New Features

New ADHD Site!

SOURCES: Teunis Geijtenbeek, Ph.D., department of molecular cell biology and immunology, Vrije University Medical Center, Amsterdam, The Netherlands; Jeffrey Laurence, M.D., professor, medicine and director, Laboratory for AIDS Virus Research, Weill Cornell Medical College, New York City; March 4, 2007, Nature Medicine online


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map